Medtronic PLC/ IE00BTN1Y115 /
15/05/2024 07:57:09 | Chg. -0.1200 | Volume | Bid21:59:58 | Ask21:59:58 | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
77.9300EUR | -0.15% | - Turnover: - |
77.8200Bid Size: 100 | 77.8800Ask Size: 100 | 103.36 bill.EUR | - | - |
GlobeNewswire
13/05
Orchestra BioMed Reports First Quarter 2024 Financial Results and Provides a Business Update
GlobeNewswire
09/05
Arecor and Medtronic Diabetes establish collaboration to develop a novel thermostable insulin for im...
GlobeNewswire
30/04
Orchestra BioMed Announces AVIM Therapy Global Intellectual Property Estate Reaches 110 Issued Paten...
GlobeNewswire
23/04
Tactile Medical Announces CEO Transition and Preliminary First Quarter 2024 Revenue
GlobeNewswire
23/04
Blue Cross and Blue Shield of Minnesota Announces Chris Boles as Vice President of Medicare, Melissa...
GlobeNewswire
27/03
Increased Adoption of Artificial Intelligence Across the Healthcare Industry Driving Strong Market G...
GlobeNewswire
26/03
Orchestra BioMed Announces Appointment of Medical Device Industry Expert David Pacitti to Board of D...
GlobeNewswire
13/03
Orchestra BioMed Demonstrates Strength of Cardiovascular Pipeline with Virtue® SAB and AVIM Therapy ...
GlobeNewswire
06/03
Orchestra BioMed Announces Presentation of Results from Clinical Study Demonstrating Favorable Hemod...
GlobeNewswire
26/02
Orchestra BioMed Presents New Data Showing Sustained Clinically Meaningful Reduction in 24-Hour Ambu...
GlobeNewswire
05/02
Inspire Medical Systems, Inc. Announces Chair Marilyn Carlson Nelson to Retire and Timothy P. Herber...
GlobeNewswire
08/01
Orchestra BioMed Announces Initiation of BACKBEAT Pivotal Study of AVIM Therapy in Hypertensive Pace...
GlobeNewswire
29/12/2023
Visionary Leadership: HMG Strategy, the World’s #1 Executive Leadership Network, Looks Ahead to its ...
GlobeNewswire
13/11/2023
Orchestra BioMed Reports Third Quarter 2023 Financial Results and Provides Business Update